1 |
郑莹,吴春晓,张敏璐. 乳腺癌在中国的流行状况和疾病特征[J]. 中国癌症杂志, 2013, 23(8):561-569.
|
2 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1):5-29.
|
3 |
Mondal D, Sharma DN. External beam radiation techniques for breast cancer in the new millennium: New challenging perspectives[J]. J Egypt Natl Canc Inst, 2016, 28(4):211-218.
|
4 |
Bernal-Estévez D, Sánchez R, Tejada RE, et al. Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient[J]. BMC Cancer, 2016, 16:591.
|
5 |
Nakai K, Hung MC, Yamaguchi H. A perspective on anti-EGFR therapies targeting triple-negative breast cancer[J]. Am J Cancer Res, 2016, 6(8):1609-1623.
|
6 |
Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer[J]. N Engl J Med, 2010, 363(20):1938-1948.
|
7 |
Rapoport AP, Stadtmauer EA, Binder-Scholl GK, et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma[J]. Nat Med, 2015, 21(8):914-921.
|
8 |
Chinnasamy N, Wargo JA, Yu Z, et al. A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer[J]. J Immunol, 2011, 186(2):685-696.
|
9 |
Chodon T, Comin-Anduix B, Chmielowski B, et al. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma[J]. Clin Cancer Res, 2014, 20(9):2457-2465.
|
10 |
Parkhurst MR, Joo J, Riley JP, et al. Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells[J]. Clin Cancer Res, 2009, 15(1):169-180.
|
11 |
Koslowski M, Sahin U, Mitnacht-Kraus R, et al. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes[J]. Cancer Res, 2007, 67(19): 9528-9534.
|
12 |
Devor EJ, Leslie KK. The oncoplacental gene placenta-specific protein 1 is highly expressed in endometrial tumors and cell lines[J]. Obstet Gynecol Int, 2013, 2013:807849.
|
13 |
Koslowski M, Tureci O, Biesterfeld S, et al. Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2[J]. J Biol Chem, 2009, 284(42):28607-28615.
|
14 |
Sommermeyer D, Conrad H, Kroenig H, et al. NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability[J]. Int J Cancer, 2013, 132(6):1360-1367.
|
15 |
Fortmüller K, Alt K, Gierschner D, et al. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA x CD3 bispecific single-chain diabody[J]. Prostate, 2011, 71(6):588-596.
|
16 |
徐梅,李丹,蒋敬庭,等. CIK细胞联合紫杉醇对卵巢癌SKOV-3细胞的体外杀伤效应[J]. 肿瘤, 2014, 34(7):591-595.
|
17 |
Adamina M. When gene therapy meets adoptive cell therapy: better days ahead for cancer immunotherapy?[J]. Expert Rev Vaccines, 2010, 9(4):359-363.
|
18 |
Cocchia M, Huber R, Pantano S, et al. PLAC1, an Xq26 gene with placenta-specific expression[J]. Genomics, 2000, 68(3):305-312.
|
19 |
Liu W, Zhai M, Wu Z, et al. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer[J]. Amino Acids, 2012, 42(6):2257-2265.
|
20 |
Gammaitoni L, Giraudo L, Leuci V, et al. Effective activity of cytokine-Induced killer cells against autologous metastatic melanoma including cells with stemness features[J]. Clin Cancer Res, 2013, 19(16):4347-4358.
|